Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of

CAMBRIDGE, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develo...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Gina Nugent , Laurence Watts , Kiki Patel , Ben Zeskind , Thomasj Schall , Schering , Stanford University , Plough Corporation , Chemocentryx Inc , Amgen , Gilmartin Group , Immuneering Corporation Nasdaq , Immuneering Corporation , Nugent Communications , Northern Illinois University , Research Institute , Genentech Inc , Chief Executive Officer ,